基于"三证三法"理论论治新型冠状病毒肺炎  

Treatment of corona virus disease 2019 based on the theory of"three syndromes and three methods"

作　　者：李志军[1] 李银平[2] 王博超[1] Li Zhijun;Li Yinping;Wang Bochao(Tianjin First Center Hospital,Tianjin 300192,China;Tianjin Hospital,Tianjin 300050,China)

机构地区：[1]天津市第一中心医院,300192 [2]天津市天津医院,300050

出　　处：《中国中西医结合急救杂志》2020年第1期10-12,共3页Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care

摘　　要：新型冠状病毒肺炎的最新诊疗方案(第四版)已经印发,诊疗方案中突出了中西医结合治疗理念,并3次提及血必净注射液.血必净注射液是基于"三证三法"理论研制而成."三证三法"理论是20世纪70年代王今达教授及其团队提出的关于危重疾病的中西医结合辨证理论体系,是王今达学术思想的主要内容之一."三证三法"理论具有深厚的中医理论基础支撑,并且仍在不断地丰富与完善,同时也有多个循证数据支持.因此,"三证三法"具有丰富的理论内涵和顽强的生命力.The latest diagnosis and treatment plan(4th edition)of corona virus disease 2019(COVID-19)has been issued.The diagnosis and treatment plan highlights the concept of integrated traditional Chinese and Western medicine,and Xuebijing injection has been referred for three times.Xuebijing injection is successfully developed based on the theory of"three syndromes and three methods".The theory of"three syndromes and three methods"is a theoretical system of integrated traditional Chinese and Western medicine on critical diseases proposed by Professor Wang Jinda and his team in the 1970s,and it is one of the main contents of Wang Jinda's academic thought.The theory of"three syndromes and three methods"has a deep foundation of traditional Chinese medicine theory,and it is still being continuously enriched and improved.It is also supported by multiple evidence-based data.Therefore,"three syndromes and three methods"is rich in theoretical connotation and tenacious vitality.

关 键 词：新型冠状病毒肺炎 三证三法 血必净注射液 

分 类 号：S85[农业科学—兽医学]